Petros Pharmaceuticals: Set for best day on strong Q1

Petros Pharmaceuticals

17/05/2021 17:07

** Shares of provider of therapeutics for men's health
 PTPI.O  surge 42% to $4.25, set for biggest daily pct. gain on
record
    ** Q1 net sales rise to $4.1 mln vs $1.8 mln last year
    ** Net income was $3 mln vs a loss of $6.1 mln last year,
primarily due to increased net sales and margins, lower
operating expenses  urn:newsml:reuters.com:*:nPn98Vk45a
    ** PTPI says there was 300% increase in its erectile
dysfunction therapy, Stendra, during Q1 2021 vs last year
    ** Company enjoyed an emerging post-COVID-19 optimism from
prescribers, consumers and distribution channels, which created
a favorable environment for increased prescriptions - President
Fady Boctor
    ** Stock down 10.6% so far this year

 (Reporting by Shreyasee Raj in Bengaluru)
 ((Shreyasee.Raj@thomsonreuters.com;))